Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients

Journal of Infectious Diseases

Volumn 185, Issue 9, 2002, Pages 1238-1243

  Jenkins, Frank J ^a,b,c   Hoffman, Linda J ^b   Liegey Dougall, Angela ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; STEROID; TACROLIMUS; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS INFECTION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; SEX FACTORS; VIRUS ACTIVATION;

EID: 0036569132     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340237     Document Type: Article

References (46)

1. Viral complications after transplantation
2. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
3. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8
4. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS
5. Human herpesvirus type 8 and Kaposi's sarcoma
6. Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy
7. Kaposi's sarcoma in renal transplant recipients
8. Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy
9. Detection and subtyping of human herpesvirus-8 in renal transplant patients before and after remission of Kaposi's sarcoma
10. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: Report of 13 cases
11. Kaposi's sarcoma as manifestation of immunosuppression in organ transplant recipients
12. Kaposi sarcoma in renal transplant recipients
13. Infection with human immunodeficiency virus in the Pittsburgh transplant population: A study of 583 donors and 1043 recipients, 1981-1986
14. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
15. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
16. Human herpesvirus 8 infection occurs following adolescence in the United States
17. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex
18. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients
19. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients
20. Transplantation-associated Kaposi's sarcoma: Herpesvirus 8 transmission through renal allografts
21. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients
22. Posttransplant human herpes virus 8 infection and seroconversion in a Kaposi's sarcoma affected kidney recipient transplanted from a human herpes virus 8 positive living related donor
23. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
24. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission
25. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): Epidemiology and pathogenesis
26. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients
27. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection
28. Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus
29. Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients
30. Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients
31. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus
32. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates
33. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma
34. Mucosal shedding of human herpesvirus 8 in men
35. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents
36. Detection of antibodies to human herpesvirus 8 in Italian children: Evidence for horizontal transmission
37. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa
38. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population
39. Increasing probability of mother-to-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8
40. Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients
41. Bone marrow failure associated with human herpesvirus 8 infection after transplantation
42. Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation
43. Comparison of serologic assays for detection of antibodies against human herpesvirus 8
44. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda; multicentre study with multiple and novel assays
45. Reactivities of human sera with human herpesvirus-8-infected BCBL-I cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs
46. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection